MIDKINE CAN BE EVALUATED AS A NEW OVARIAN RESERVE MARKER AT POLYCYSTIC OVARY SYNDROME CASES EXCEPT FOR UNEXPLAINED INFERTILITY CASES.

dc.contributor.author	Ghalyoun Farouk
dc.contributor.author	Unver Alcay Ayla
dc.date.accessioned	2019-07-10T13:27:14Z
dc.date.available	2019-07-10T13:27:14Z
dc.date.issued	2018
dc.identifier.uri	http://hdl.handle.net/11547/2771
dc.publisher	FERTILITY AND STERILITY
dc.title	MIDKINE CAN BE EVALUATED AS A NEW OVARIAN RESERVE MARKER AT POLYCYSTIC OVARY SYNDROME CASES EXCEPT FOR UNEXPLAINED INFERTILITY CASES.
dc.publisher.volume	110
dc.publisher.issue	4
dc.publisher.firstpagenumber	E325
dc.publisher.lastpagenumber	E326
dc.identifier.doinumber	10.1016/j.fertnstert.2018.07.914
dc.identifier.wos	WOS:000448713601232